Search research articles
Contact Us
Filters
Showing results (121-130 of 184) with videos related to
Page
of 19
Sort By:
Anticancer Research
|
March 26, 2002
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study
C Gridelli, C Curcio, R V Iaffaioli, et al.
ESMO Open
|
April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
N Silvestris, M Di Maio, A Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2014
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
F Pietrantonio, F Perrone, F de Braud, et al.
British Journal of Cancer
|
May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group
S Pignata, G Scambia, C Pisano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2008
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
F Perrone, A Lampis, M Orsenigo, et al.
ESMO Open
|
June 11, 2025
Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)
M Del Re, R Roncato, A Argentiero, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
British Journal of Cancer
|
August 23, 2000
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators
C Gridelli, L Frontini, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
A Necchi, S Lo Vullo, P Giannatempo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
L Licitra, F Perrone, E Tamborini, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 184) with videos related to
Sort By:
Page
of 19
Anticancer Research
|
March 26, 2002
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study
C Gridelli, C Curcio, R V Iaffaioli, et al.
ESMO Open
|
April 5, 2021
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
N Silvestris, M Di Maio, A Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2014
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
F Pietrantonio, F Perrone, F de Braud, et al.
British Journal of Cancer
|
May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group
S Pignata, G Scambia, C Pisano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2008
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
F Perrone, A Lampis, M Orsenigo, et al.
ESMO Open
|
June 11, 2025
Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)
M Del Re, R Roncato, A Argentiero, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumors
A Morabito, M C Piccirillo, R Costanzo, et al.
British Journal of Cancer
|
August 23, 2000
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators
C Gridelli, L Frontini, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
A Necchi, S Lo Vullo, P Giannatempo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2011
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients
L Licitra, F Perrone, E Tamborini, et al.
Page
of 19